Francesca Isabella Tosetti
Francesca Isabella Tosetti
Staff Scientist, IRCCS Policlinico S Martino
Email verificata su hsanmartino.it
Titolo
Citata da
Citata da
Anno
‘Angioprevention’: angiogenesis is a common and key target for cancer chemopreventive agents
F Tosetti, N Ferrari, S De Flora, A Albini
The FASEB Journal 16 (1), 2-14, 2002
3782002
Cancer prevention by targeting angiogenesis
A Albini, F Tosetti, VW Li, DM Noonan, WW Li
Nature reviews Clinical oncology 9 (9), 498-509, 2012
2622012
Tumor inflammatory angiogenesis and its chemoprevention
A Albini, F Tosetti, R Benelli, DM Noonan
Cancer research 65 (23), 10637-10641, 2005
2232005
Anti-angiogenesis and angioprevention: mechanisms, problems and perspectives
D Bisacchi, R Benelli, C Vanzetto, N Ferrari, F Tosetti, A Albini
Cancer detection and prevention 27 (3), 229-238, 2003
1082003
The engagement of CTLA-4 on primary melanoma cell lines induces antibody-dependent cellular cytotoxicity and TNF-α production
S Laurent, P Queirolo, S Boero, S Salvi, P Piccioli, S Boccardo, ...
Journal of translational medicine 11 (1), 108, 2013
932013
Retinol binding protein and transthyretin are secreted as a complex formed in the endoplasmic reticulum in HepG2 human hepatocarcinoma cells
D Bellovino, T Morimoto, F Tosetti, S Gaetani
Experimental cell research 222 (1), 77-83, 1996
801996
The redox state of the lung cancer microenvironment depends on the levels of thioredoxin expressed by tumor cells and affects tumor progression and response to prooxidants
J Ceccarelli, L Delfino, E Zappia, P Castellani, M Borghi, S Ferrini, ...
International Journal of Cancer 123 (8), 1770-1778, 2008
772008
Antileukemia effects of xanthohumol in Bcr/Abl-transformed cells involve nuclear factor-κB and p53 modulation
S Monteghirfo, F Tosetti, C Ambrosini, S Stigliani, S Pozzi, F Frassoni, ...
Molecular cancer therapeutics 7 (9), 2692-2702, 2008
702008
Metabolic regulation and redox activity as mechanisms for angioprevention by dietary phytochemicals
F Tosetti, DM Noonan, A Albini
International journal of cancer 125 (9), 1997-2003, 2009
642009
Growth factor supplemented matrigel improves ectopic skeletal muscle formation—a cell therapy approach
A Barbero, R Benelli, S Minghelli, F Tosetti, A Dorcaratto, C Ponzetto, ...
Journal of Cellular Physiology 186 (2), 183-192, 2001
602001
N-(4-hydroxyphenyl) retinamide inhibits retinoblastoma growth through reactive oxygen species-mediated cell death
F Tosetti, R Venč, G Arena, M Morini, S Minghelli, DM Noonan, A Albini
Molecular pharmacology 63 (3), 565-573, 2003
472003
The chemopreventive retinoid 4HPR impairs prostate cancer cell migration and invasion by interfering with FAK/AKT/GSK3β pathway and β-catenin stability
R Benelli, S Monteghirfo, R Venč, F Tosetti, N Ferrari
Molecular cancer 9 (1), 1-13, 2010
452010
Xanthohumol impairs human prostate cancer cell growth and invasion and diminishes the incidence and progression of advanced tumors in TRAMP mice
R Venč, R Benelli, S Minghelli, S Astigiano, F Tosetti, N Ferrari
Molecular medicine 18 (9), 1292-1302, 2012
432012
Diet-derived phytochemicals: from cancer chemoprevention to cardio-oncological prevention
N Ferrari, F Tosetti, S De Flora, F Donatelli, I Sogno, D M Noonan, A Albini
Current Drug Targets 12 (13), 1909-1924, 2011
432011
Glycogen synthase kinase 3β regulates cell death induced by synthetic triterpenoids
R Vene, P Larghero, G Arena, MB Sporn, A Albini, F Tosetti
Cancer research 68 (17), 6987-6996, 2008
392008
Angioprevention with fenretinide: targeting angiogenesis in prevention and therapeutic strategies
I Sogno, R Venč, N Ferrari, A De Censi, A Imperatori, DM Noonan, ...
Critical reviews in oncology/hematology 75 (1), 2-14, 2010
382010
ADAM10 new selective inhibitors reduce NKG2D ligand release sensitizing Hodgkin lymphoma cells to NKG2D-mediated killing
MR Zocchi, C Camodeca, E Nuti, A Rossello, R Venč, F Tosetti, I Dapino, ...
Oncoimmunology 5 (5), e1123367, 2016
262016
Evidence of epidermal growth factor receptor expression in uveal melanoma: inhibition of epidermal growth factor-mediated signalling by Gefitinib and Cetuximab triggered …
A Amaro, V Mirisola, G Angelini, A Musso, F Tosetti, AI Esposito, P Perri, ...
European Journal of Cancer 49 (15), 3353-3365, 2013
262013
Anti-angiogenic properties of Chemopreventive Drugs: Fenretinide as a Prototype.
I Sogno, R Venč, C Sapienza, N Ferrari, F Tosetti, A Albini
Cancer Prevention II, 71-76, 2009
222009
Novel cell death pathways induced by N-(4-hydroxyphenyl) retinamide: therapeutic implications
R Vene, G Arena, A Poggi, C D'Arrigo, M Mormino, DM Noonan, A Albini, ...
Molecular cancer therapeutics 6 (1), 286-298, 2007
222007
Il sistema al momento non puņ eseguire l'operazione. Riprova pił tardi.
Articoli 1–20